Acutus Medical, Inc.

Acutus Medical, Inc.

AFIB
Acutus Medical, Inc.US flagOther OTC
0.00
USD
- -
- -
2,991.00Market Cap

Total Valuation

Acutus Medical, Inc. carries a market capitalization of 2,991.00, placing it among publicly traded companies globally. Its enterprise value stands at 23.38M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2,991.00
Enterprise Value23.38M

Share Statistics

Acutus Medical, Inc. currently has 29.91M shares outstanding.

Shares Outstanding29.91M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.08, and the price-to-book ratio stands at 0.00.

PE RatioN/A
PS Ratio0.08
PB Ratio0.00
P/TBV Ratio-0.14
P/FCF Ratio-0.05
P/OCF Ratio-0.05

Enterprise Valuation

On an enterprise value basis, Acutus Medical, Inc. trades at an EV/EBITDA multiple of 3.84 and an EV/FCF ratio of 1.49. The EV/Sales ratio of 1.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.40 provides insight into valuation relative to core operating earnings.

EV / Sales1.16
EV / EBITDA3.84
EV / EBIT3.40
EV / FCF1.49

Financial Position

Acutus Medical, Inc. maintains a current ratio of 2.06, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -308.52, indicating conservative leverage, while an interest coverage ratio of -1.46 demonstrates limited ability to service its debt obligations.

Current Ratio2.06
Quick Ratio1.76
Debt / Equity-308.52
Debt / EBITDA-4.26
Interest Coverage-1.46

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-23.11
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover6.31

Stock Price Statistics

Acutus Medical, Inc.'s stock has declined approximately -50% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Beta (5Y)N/A
52-Week Price Change-50%
50-Day Moving Average0.00
200-Day Moving Average0.00
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Acutus Medical, Inc. generated 20.15M in revenue and converted that into -9.55M in net income, yielding earnings per share of -0.15. EBITDA reached -8.40M, while operating income came in at -9.43M.

Revenue20.15M
Gross Profit1.00M
Operating Income-9.43M
Pretax Income-4.54M
Net Income-9.55M
EBITDA-8.40M
EBIT-9.43M
Earnings Per Share (EPS)-0.15

Balance Sheet

Acutus Medical, Inc. holds 14.02M in cash and equivalents against 35.76M in total debt, resulting in a net debt position of 18.55M. Total book value stands at -609.49M, with working capital of 13.14M providing operational flexibility.

Cash & Cash Equivalents14.02M
Total Debt35.76M
Net Debt18.55M
Equity (Book Value)-609.49M
Book Value Per Share-20.50
Working Capital13.14M

Cash Flow

Acutus Medical, Inc. produced -31.66M in operating cash flow over the past twelve months. After subtracting -112,000.00 in capital expenditures, free cash flow totaled -31.77M - equivalent to -1.07 per share.

Operating Cash Flow-31.66M
Capital Expenditures-112,000.00
Free Cash Flow-31.77M
FCF Per Share-1.07

Margins

Acutus Medical, Inc. operates with a gross margin of 4.98, reflecting its pricing power and cost economics. The operating margin of -46.81 and net profit margin of -47.38 provide insight into operational efficiency.

Gross Margin4.98
Operating Margin-46.81
Pretax Margin-22.55
Profit Margin-47.38
EBITDA Margin-41.72

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield176.75
FCF Yield-1,928.83

Scores

Acutus Medical, Inc. posts an Altman Z-Score of -29.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-29.60